Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Penn Medicine: Philadelphia, PA, US

2001-07-01 to present | Clinical Professor of Medicine (General Internal Medicine)
Employment
Source: Self-asserted source
Matthew Miller

Education and qualifications (1)

Thomas Jefferson University: Philadelphia, PA, US

1977-09-01 to 1981-06-01 | MD
Education
Source: Self-asserted source
Matthew Miller

Professional activities (3)

American College of Physicians: Philadelphia, US

2023-04-01 to present | Member (Clinical Guidelines Committee)
Invited position
Source: Self-asserted source
Matthew Miller

American College of Physicians: Philadelphia, PA, US

2020-02-01 to present | Member, COVID Subcommittee, Population Health and Medical Science Committee
Service
Source: Self-asserted source
Matthew Miller

American College of Physicians: Philadelphia, PA, US

2011-07 | FACP
Distinction
Source: Self-asserted source
Matthew Miller

Works (13)

Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert)

Annals of Internal Medicine
2024-08 | Journal article
DOI: 10.7326/ANNALS-24-00128
Contributors: Amir Qaseem; Jennifer Yost; George M. Abraham; Rebecca A. Andrews; Janet A. Jokela; Matthew C. Miller; Linda L. Humphrey; Linda L. Humphrey; Adam J. Obley; Adam J. Obley et al.
Source: check_circle
Crossref

Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2)

Annals of Internal Medicine
2023-10 | Journal article
DOI: 10.7326/M23-1636
Contributors: Amir Qaseem; Jennifer Yost; George M. Abraham; Rebecca Andrews; Janet A. Jokela; Matthew C. Miller; Linda L. Humphrey; Linda L. Humphrey; Adam J. Obley; Elie A. Akl et al.
Source: check_circle
Crossref

Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)

Annals of Internal Medicine
2023-01 | Journal article
DOI: 10.7326/M22-2249
Contributors: Amir Qaseem; Jennifer Yost; Matthew C. Miller; Rebecca Andrews; Janet A. Jokela; Mary Ann Forciea; George M. Abraham; Linda L. Humphrey
Source: check_circle
Crossref

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

Annals of Internal Medicine
2022-05 | Journal article
DOI: 10.7326/M21-4810
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Mary Ann Forciea; Matthew C. Miller; Linda L. Humphrey
Source: check_circle
Crossref

What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Annals of Internal Medicine
2022-04 | Journal article
DOI: 10.7326/M21-3272
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; Mary Ann Forciea; George M. Abraham; Matthew C. Miller; Adam J. Obley; Linda L. Humphrey; Elie A. Akl; Rebecca Andrews et al.
Source: check_circle
Crossref

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Annals of Internal Medicine
2021-12 | Journal article
DOI: 10.7326/L21-0607
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Matthew C. Miller; Mary Ann Forciea; Linda L. Humphrey
Source: check_circle
Crossref

Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Annals of Internal Medicine
2021-09 | Journal article
DOI: 10.7326/L21-0389
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Matthew C. Miller; Mary Ann Forciea; Linda L. Humphrey
Source: check_circle
Crossref

The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians

Annals of Internal Medicine
2021-08 | Journal article
DOI: 10.7326/M20-7641
Contributors: Amir Qaseem; Jennifer Yost; Mary Ann Forciea; Janet A. Jokela; Matthew C. Miller; Adam Obley; Linda L. Humphrey
Source: check_circle
Crossref

What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1)

Annals of Internal Medicine
2021-06-16 | Journal article
DOI: 10.7326/M20-7569
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; Mary Ann Forciea; George M. Abraham; Matthew C. Miller; Adam J. Obley; Linda L. Humphrey
Source: check_circle
Crossref

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Annals of Internal Medicine
2021-05-09 | Journal article
DOI: 10.7326/M20-8101
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Mary Ann Forciea; Matthew C. Miller; Linda L. Humphrey
Source: check_circle
Crossref

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)

Annals of Internal Medicine
2021-02-05 | Journal article
DOI: 10.7326/M20-5831
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Mary Ann Forciea; Matthew C. Miller; Linda L. Humphrey
Source: check_circle
Crossref

Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1)

Annals of Internal Medicine
2020-10-20 | Journal article
DOI: 10.7326/M20-3234
Contributors: Amir Qaseem; Itziar Etxeandia-Ikobaltzeta; Jennifer Yost; Matthew C. Miller; George M. Abraham; Adam J. Obley; Mary Ann Forciea; Janet A. Jokela; Linda L. Humphrey
Source: check_circle
Crossref

Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians

Annals of Internal Medicine
2020-07-21 | Journal article
DOI: 10.7326/M20-3862
Contributors: Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; Matthew C. Miller; George M. Abraham; Adam J. Obley; Mary Ann Forciea; Janet A. Jokela; Linda L. Humphrey
Source: check_circle
Crossref
How many people are using ORCID?